Tomson times health 3500000000 yuan to buy Australian probiotics company Life-Space

Pharmaceutical Network February 2 News took the lead in the concept of 'dietary supplements' into China's Tomson times Kin, after the listing has been the forerunner of the domestic health care products industry. The repayment of funds to buy probiotics in Australia, can be considered with a The domestic capital acquisition of Australian health care products business trend.After the success of this transaction, the next to be bought by the domestic capital of Australian health care products enterprises who? We will wait and see.

On January 31, Tomson Trading Co., Ltd. announced in a public announcement that Australia By Saint Pty Ltd., a wholly-owned subsidiary of the Company, intends to sign the Share Sale Agreement with Irene Messer, Alan Messer and Craig Silbery for the purchase of Life- Space Group Pty Ltd. The total consideration for the transaction will not exceed A $ 69,000 million (approximately RMB3,533 million at 31-day exchange rate) and the final transaction price will be adjusted in accordance with the relevant agreement of the Share Sale Agreement , And pending the company audit organizations, assessment agencies to carry out the corresponding work and audit, assessment report submitted to the Board of Directors, shareholders meeting examined and approved.

On this funding source, Tomson times Kin said it will use its own funds and bank loans.In addition the company will actively seek strategic partners to set up joint ventures (domestic SPV) acquisition of the underlying company, the future by the joint venture company to pay the purchase price of the underlying company .

According to publicly available data, Life-Space Group was founded in 1993 and is one of the largest probiotic companies in Australia with its headquarters in Melbourne. Life-Space Group's leading brand is Life-Space, which covers people of all ages In 2014, Life-Space entered the Chinese market through cross-border e-commerce. At present, Life-Space Probiotics products have gained a good reputation and brand foundation in Australia and China market, and are highly recognized by consumers.

With the rising global consumer health awareness and healthy consumer market matures, consumer demand is also escalating, the dietary supplement market presents a trend of segmentation and personalization in recent years, the probiotics market in the world has been rapid development And popularity of Europe Rui data show that the global probiotic products (including probiotic supplements and probiotics yogurt) market size of about 36 billion US dollars in 2017. Probiotic products (including probiotic supplements and probiotic yogurt) market size About 45.5 billion yuan, is expected to grow to 89.6 billion yuan in 2022. Among them, the probiotics supplement market has become one of the fastest growing segments.

Tomson times Kin said that the acquisition is Tomson times health in the global market segments an important part of the layout, but also the company following the 'big single product' model, e-commerce brand, cross-border e-commerce and other three major market strategy A major move will be to fully integrate the resources and advantages of the target companies in the probiotic market, to achieve synergies between the two sides at the product and business levels and to find new growth opportunities to create greater value for Tomsonkay Shareholders.

In addition, Ben HcHarg, Managing Director of Life-Space, said in the Australian media "Australian Financial Review Network" that the new owner Tommy Hsien will retain Life-Space's current production and management.

According to the Xin Kang sector reported before: Deer 208.4 billion US dollars health care market, Nestle strong 2.3 billion US dollars into the killings in recent years with the improvement of living standards of our residents, health awareness has also been increasing, the rapid growth of the domestic health products industry.According to Euromonitor data , 2016 in our country Healthy food Market size reached 134.6 billion yuan, a compound annual growth rate of 13%, and maintained rapid growth for many years. Roland Berger had predicted that the future of China Health products The market will still grow at a rate higher than GDP. It is estimated that the market scale will be about 180 billion yuan by 2020.

Founded in April 2005 Tomson times health, China's health products industry's first AAA credit rating enterprise , Which is also a leader in the domestic healthcare products industry, benefited from the rapid development of the domestic healthcare products industry. Since the listing of Tomson Science, the company has less interest-bearing liabilities (including short / long-term borrowings and bonds payable), keeping its gearing ratio at Low, providing strong support for its outward mergers and acquisitions, the last three years have invested 900 million yuan total investment of 16 companies stake, the acquisition of Life-Space also in line with the main direction of Tomson times health.

It is noteworthy that in recent years in the health care products in the circle of mergers and acquisitions, Australian health products companies seem to have become the 'hot money' for domestic capitalists.

◆ In September 2015, BIOSTIME Hong Kong acquired 83% of Swisse, an Australian health care company, for a total investment of nearly 1.386 billion Australian dollars through two acquisitions;

◆ In July 2016, Hopsone received A $ 311 million of remaining equity interest in Swisse to achieve full control;

◆ August 2016, Shanghai medicine , Chunhua Capital spent 1.565 billion yuan, the acquisition of Vitaco 100% stake;

◆ In August 2016, New Hope's Kenwood acquired Australian Natural Care, an Australian health brand, and officially entered the field of nutrition and health.

◆ In August 2016, AUO spent 160 million yuan to acquire NutritionCare, a high-end Australian nutrition and nutraceutical company.

◆ In January 2018, CCB Investment, CITIC Capital and Bain Capital bid for Nature's Care, an Australian health products company, valued at 700 million Australian dollars (about 600 million U.S. dollars).

Why Australian health care products companies are so favored by the domestic capital side? According to the latest published KPMG and the University of Sydney joint study, which is mainly benefited from the signing of Sino-Australian Free Trade Agreement and the implementation of the agreement, as well as the Australian Pharmaceutical Development Mechanism , Incentives for national innovation and other preferential policies.The report pointed out that with the continuous expansion of China's middle income groups, the Chinese market for clean, affluent and healthy food in Australia unabated.With the aging of society in China further intensified, Australia is more robust Pension health care system, advanced medical insurance concepts and services, will be greatly concerned by Chinese investors.

And domestic consumers are also more trustworthy about Australian health products, which show that, unlike most of the more loosely managed health foods listed in most countries in the world, the Federal Drug Administration (TGA) is the first to list health products as drug , And through the legislation to strictly control the TGA for the health care products from raw materials procurement, testing, production processes and processes, to the finished product packaging and testing, and other aspects of the drug requirements to develop a clear specification.Australian health products must be in strict accordance with the Australian TGA And the World Health Organization announced GMP double standards of production, together with the diversity of Australian health products and moderate prices, so that in the eyes of Chinese consumers set a good reputation.

Following the acquisition of Life-Space by Tomson Muskete, who is the next Australian healthcare company to be hit by domestic capital? Worth Looking Forward.